Earnings call Presentation.

Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Date: August 11, 2026 Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block BSE Scrip Code: 544339 Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: LAXMIDENTL Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020 Dear Sir(s)/Madam(s), Sub: Investor Presentation on Q1FY27 Earnings Conference Call of Laxmi Dental Limited (“the Company”). Pursuant to Regulation 30(6) read with Schedule III Part A Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the copy of Investor Presentation for Q1FY27 Earning Conference Call on unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. The aforesaid shall also be available on the website of the Company i.e. https://www.laxmidentallimited.com/for-investors. Kindly take the above on record. Thanking you, For Laxmi Dental Limited -------------------------------------------------- Suman Saha Company Secretary and Compliance Officer ICSI Membership Number: A33035 Encl.: As above. Q1FY27 Investor Presentation August 2026 Safe harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Laxmi Dental Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. Table of contents Performance Highlights Industry Overview Business Overview Strategies Financial & Operational Performance Annexures Performance Highlights Performance Highlights Industry Overview Business Overview Strategies Financial & Operational Performance Annexures Management commentary “We are pleased to report a strong start to FY27, with Q1 revenue reaching our highest-ever quarterly level of around ₹75.0 crore, representing year-on-year growth of 13.9%. The performance was broad-based, led by healthy momentum in our Dental Laboratory business and our Aligner Solutions business. Our profitability during the quarter witnessed some improvement largely on account of a better product mix. We are strengthening our on-ground leadership presence in the U.S. to sharpen our market-focused strategy and sustain healthy growth in this market. In India, we have established 3 new support facilities across multiple cities to deepen our regional presence, enhance market penetration and provide better service to our existing dental partners. Rajesh Khakhar Going forward, a focus on core dental portfolio, deeper market penetration, AI-led automation, and improving operational efficiencies Chairperson and Whole-Time Director enables Laxmi Dental to deliver healthy and sustainable performance.” “Our robust performance in Q1FY27 reflects the sustained efforts of our sales and operations teams, supported by scanner deployments in the past, training programs, promotional activities, participation in dental events and digital initiatives. For the quarter our dental laboratory business grew by 23.5% year-on-year, with international operations registering particularly strong growth of 37.4%, reflecting our relationships and market presence across global markets. Aligner Solutions business also maintained its momentum, growing 28.6% year-on-year, with both Bizdent and Vedia delivering healthy growth of 27.8% and 29.3% respectively. With continued progress in digitalization, innovation, branding and dental network expansion, we remain well positioned to deliver Sameer Merchant sustainable and profitable growth for the upcoming years.” Managing Director and CEO Performance Highlights Industry Overview Business Overview Strategies Financial & Operational Performance Annexures Statement of Profit & Loss Figures in INR mn Consolidated P&L(INR Mn) Q1FY27 Q1FY26 YoY Q4FY26 Q-o-Q FY26 Revenues 747.0 656.0 13.9% 739.5 1.0% 2,778.6 Q1FY27 Performance Highlights: Cost of Goods Sold 160.0 175.1 218.3 821.9 • Highest-ever quarterly revenue with 13.9% YoY growth. Gross Profit 587.0 480.9 22.1% 521.3 12.6% 1,956.7 Gross Profit Margin 78.6% 73.3% 70.5% 70.4% • Gross margins stood at 78.6%, which is a year-on-year and Employee Cost 284.2 236.3 267.6 1,021.0 sequential improvement; driven by change in product mix. Other Expenses 159.2 125.5 118.7 501.7 EBITDA 143.6 119.1 20.6% 135.0 6.4% 434.0 • Gross Margins for the Core Dental Business EBITDA Margin 19.2% 18.2% 18.3% 15.6% excluding scanner sales has marginally improved. Depreciation & Amortization 43.2 35.7 43.8 158.8 Other Income 23.0 17.2 23.6 85.5 • Scanner sales contribution for the quarter was EBIT 123.4 100.5 22.7% 114.8 7.5% 360.7 minimal. EBIT Margin 16.5% 15.3% 15.5% 13.0% Finance Cost 3.0 4.6 3.5 13.7 • Sequential increase in employee costs is mainly due to Exceptional Items 0.0 0.0 0.0 -57.8 appointment of new CEO for USA business and addition of Profit before Tax 120.4 95.9 25.5% 111.4 8.1% 289.3 people in sales and other important areas. Tax 24.9 22.9 5.0 25.0 PAT before share of profit/loss from JVs 95.5 73.1 30.7% 106.3 -10.2% 264.3 • ESOP expenses, which are non-cash in nature, amounted PAT Margin 12.8% 11.1% 14.4% 9.5% to INR 8.3 Mn in Q1FY27 as against INR 18.4 Mn in Q1FY26. Share of Profit from JVs 7.7 10.2 -5.4 24.9 • Other expenses increased largely on account of higher PAT after share of profit/loss from JVs 103.2 83.3 23.8% 100.9 2.2% 289.2 freight cost and ECL (provisions) as well as spending PAT Margin 13.8% 12.7% 13.6% 10.4% Basic EPS (in INR) 1.87 1.53 1.83 5.27 towards AI led automation initiatives which are important Diluted EPS (in INR) 1.87 1.52 1.83 5.26 for efficient scalability in future. Adjusted EBITDA 159.6 147.7 8.0% 13 [Showing first 8,000 characters — download PDF for full document]